[Effect of preoperative irradiation on histological tumor propagation and on the frequency of vaginal recurrence of uterine cancer].

G. Keller,E. Kuhn,K. Krommer,K. Méhes

1971-01-23

Zentralblatt für Gynäkologie

Abstract:

What problem does this paper attempt to address?

Clinical implementation of failure modes and effects analysis for gynecological high-dose-rate brachytherapy

Siyao Liu,Emma Jones

DOI: https://doi.org/10.5114/jcb.2024.136295

2024-01-01

Journal of Contemporary Brachytherapy

Abstract:Purpose: To use failure modes and effects analysis (FMEA) to identify failure modes for gynecological high-dose-rate (HDR) brachytherapy pathway and score with severity, occurrence, and detectability.Material and methods: A research team was organized to observe gynecological HDR brachytherapy pathway, and draw detailed process map to identify all potential failure modes (FMs). The whole team scored FMs based on three parameters, including occurrence (O), detectability (D), and severity (S), and then multiplied three scores to obtain risk priority number (RPN). All FMs were ranked according to RPNs and/or severity scores, and FMs with the highest RPN scores (> 100) and severity scores (> 8) were selected for in-depth analysis. Fault tree analysis (FTA) was applied to find progenitor causes of high-risk FMs and their propagation path, and determine which steps in the process need to be changed and optimized. Efficiency of each existing preventive methods to detect and stop FMs was analyzed, and proposals to improve quality management (QM) and ensure patient safety were suggested.Results: The whole gynecological HDR brachytherapy pathway consisted of 5 sub-processes and 30 specific steps, in which 57 FMs were identified. Twelve high-risk FMs were found, including 7 FMs with RPNs > 100 and 5 FMs with severity scores > 8. For these FMs, 2 were in the insertion stage, 1 in the imaging stage, 4 in the treatment planning stage, and 5 in the final stage of treatment delivery. The most serious of these FMs was the change in organ at risk (OAR) during treatment delivery (RPN = 245.7). The FM that occurred most frequently was the applicator shift during patient transfer.Conclusions: Failure modes and effects analysis is a prospective risk-based tool that can identity high-risk steps before failures occur, provide preventive measures to stop their occurrence, and improve quality management system.

oncology,radiology, nuclear medicine & medical imaging
Practical implementation of failure mode and effects analysis for safety and efficiency in stereotactic radiosurgery

Kelly Cooper Younge,Yizhen Wang,John Thompson,Julia Giovinazzo,Marisa Finlay,Raxa Sankreacha

DOI: https://doi.org/10.1016/j.ijrobp.2014.12.033

2015-04-01

Abstract:Purpose: To improve the safety and efficiency of a new stereotactic radiosurgery program with the application of failure mode and effects analysis (FMEA) performed by a multidisciplinary team of health care professionals. Methods and materials: Representatives included physicists, therapists, dosimetrists, oncologists, and administrators. A detailed process tree was created from an initial high-level process tree to facilitate the identification of possible failure modes. Group members were asked to determine failure modes that they considered to be the highest risk before scoring failure modes. Risk priority numbers (RPNs) were determined by each group member individually and then averaged. Results: A total of 99 failure modes were identified. The 5 failure modes with an RPN above 150 were further analyzed to attempt to reduce these RPNs. Only 1 of the initial items that the group presumed to be high-risk (magnetic resonance imaging laterality reversed) was ranked in these top 5 items. New process controls were put in place to reduce the severity, occurrence, and detectability scores for all of the top 5 failure modes. Conclusions: FMEA is a valuable team activity that can assist in the creation or restructuring of a quality assurance program with the aim of improved safety, quality, and efficiency. Performing the FMEA helped group members to see how they fit into the bigger picture of the program, and it served to reduce biases and preconceived notions about which elements of the program were the riskiest.
Evaluation and improvement the safety of total marrow irradiation with helical tomotherapy using repeat failure mode and effects analysis

Jiuling Shen,Xiaoyong Wang,Di Deng,Jian Gong,Kang Tan,Hongli Zhao,Zhirong Bao,Jinping Xiao,An Liu,Yunfeng Zhou,Hui Liu,Conghua Xie

DOI: https://doi.org/10.1186/s13014-019-1433-7

IF: 4.309

2019-12-01

Radiation Oncology

Abstract:Abstract Background & purpose Helical tomotherapy has been applied to total marrow irradiation (HT-TMI). Our objective was to apply failure mode and effects analysis (FMEA) two times separated by 1 year to evaluate and improve the safety of HT-TMI. Materials and methods A multidisciplinary team was created. FMEA consists of 4 main steps: (1) Creation of a process map; (2) Identification of all potential failure mode (FM) in the process; (3) Evaluation of the occurrence (O), detectability (D) and severity of impact (S) of each FM according to a scoring criteria (1–10), with the subsequent calculation of the risk priority number (RPN=O*D*S) and (4) Identification of the feasible and effective quality control (QC) methods for the highest risks. A second FMEA was performed for the high-risk FMs based on the same risk analysis team in 1 year later. Results A total of 39 subprocesses and 122 FMs were derived. First time RPN ranged from 3 to 264.3. Twenty-five FMs were defined as being high-risk, with the top 5 FMs (first RPN/ second RPN): (1) treatment couch movement failure (264.3/102.8); (2) section plan dose junction error in delivery (236.7/110.4); (3) setup check by megavoltage computed tomography (MVCT) failure (216.8/94.6); (4) patient immobilization error (212.5/90.2) and (5) treatment interruption (204.8/134.2). A total of 20 staff members participated in the study. The second RPN value of the top 5 high-risk FMs were all decreased. Conclusion QC interventions were implemented based on the FMEA results. HT-TMI specific treatment couch tests; the arms immobilization methods and strategy of section plan dose junction in delivery were proved to be effective in the improvement of the safety.

oncology,radiology, nuclear medicine & medical imaging
Comparison of failure modes and effects analyses and time for brachytherapy ring and tandem applicator digitization between manual and solid applicator source placement methods

Adia L. Holtman,Dominic J. DiCostanzo,Charles A. Zimmerman,Gavin Graeper,Jeffrey Woollard,Daniel F. Christ,Ashley J. Cetnar

DOI: https://doi.org/10.1002/acm2.14336

2024-04-27

Journal of Applied Clinical Medical Physics

Abstract:Purpose Ring and tandem (R&T) applicator digitization is currently performed at our institution by manually defining the extent of the applicators. Digitization can also be achieved using solid applicators: predefined, 3D models with geometric constraints. This study compares R&T digitization using manual and solid applicator methods through Failure Modes and Effects Analyses (FMEAs) and comparative time studies. We aim to assess the suitability of solid applicator method implementation for R&T cases Methods Six qualified medical physicists (QMPs) and two medical physics residents scored potential modes of failure of manual digitization in an FMEA as recommended by TG‐100. Occurrence, severity, and detectability (OSD) values were averaged across respondents and then multiplied to form combined Risk Priority Numbers (RPNs) for analysis. Participants were trained to perform treatment planning using a developed solid applicator protocol and asked to score a second FMEA on the distinct process steps from the manual method. For both methods, participant digitization was timed. FMEA and time data were analyzed across methods and participant samples Results QMPs rated the RPNs of the current, manual method of digitization statistically lower than residents did. When comparing the unique FMEA steps between the two digitization methods, QMP respondents found no significant difference in RPN means. Residents, however, rated the solid applicator method as higher risk. Further, after the solid applicator method was performed twice by participants, the time to digitize plans was not significantly different from manual digitization Conclusions This study indicates the non‐inferiority of the solid applicator method to manual digitization in terms of risk, according to QMPs, and time, across all participants. Differences were found in FMEA evaluation and solid applicator technique adoption based on years of brachytherapy experience. Further practice with the solid applicator protocol is recommended because familiarity is expected to lower FMEA occurrence ratings and further reduce digitization times.

radiology, nuclear medicine & medical imaging
3D-printed brachytherapy in patients with cervical cancer: improving efficacy and safety outcomes

Zenghong Lu,Gangfeng Zhu,Zhengang Qiu,Hailiang Guo,Junyan Li,Liangjian Zheng,Cixiang Chen,Jie Che,Yi Xiang,Yili Wang

DOI: https://doi.org/10.1186/s13014-024-02536-0

IF: 4.309

2024-11-04

Radiation Oncology

Abstract:This study aims to evaluate the efficacy and safety of 3D printing technology in brachytherapy for cervical cancer, comparing its outcomes with conventional free hand implantation brachytherapy.

oncology,radiology, nuclear medicine & medical imaging
Accuracy Evaluation of a 3D-Printed Individual Template for Needle Guidance in Head and Neck Brachytherapy

Ming-Wei Huang,Jian-Guo Zhang,Lei Zheng,Shu-Ming Liu,Guang-Yan Yu

DOI: https://doi.org/10.1093/jrr/rrw033

2016-01-01

Journal of Radiation Research

Abstract:To transfer the preplan for the head and neck brachytherapy to the clinical implantation procedure, a preplan-based 3D-printed individual template for needle insertion guidance had previously been designed and used. The accuracy of needle insertion using this kind template was assessed in vivo. In the study, 25 patients with head and neck tumors were implanted with 125I radioactive seeds under the guidance of the 3D-printed individual template. Patients were divided into four groups based on the site of needle insertion: the parotid and masseter region group (nine patients); the maxillary and paranasal region group (eight patients); the submandibular and upper neck area group (five patients); and the retromandibular region group (six patients). The distance and angular deviations between the preplanned and placed needles were compared, and the complications and time required for needle insertion were assessed. The mean entrance point distance deviation for all 619 needles was 1.18 ± 0.81 mm, varying from 0.857 ± 0.545 to 1.930 ± 0.843 mm at different sites. The mean angular deviation was 2.08 ± 1.07 degrees, varying from 1.85 ± 0.93 to 2.73 ± 1.18 degrees at different sites. All needles were manually inserted to their preplanned positions in a single attempt, and the mean time to insert one needle was 7.5 s. No anatomical complications related to inaccurately placed implants were observed. Using the 3D-printed individual template for the implantation of 125I radioactive seeds in the head and neck region can accurately transfer a CT-based preplan to the brachytherapy needle insertion procedure. Moreover, the addition of individual template guidance can reduce the time required for implantation and minimize the damage to normal tissues.
Dosimetric parameters and safety analysis of 3D-printing non-coplanar template-assisted interstitial brachytherapy for non-centrally recurrent cervical cancer

Cong Wang,Yan Cheng,Yadong Song,Jia Lei,Yiqian Li,Xia Li,Huirong Shi

DOI: https://doi.org/10.3389/fonc.2023.1174470

IF: 4.7

2023-10-27

Frontiers in Oncology

Abstract:Introduction: The prognosis of patients with non-central recurrent cervical cancer (NRCC) remains poor, and treatment options are limited. We aimed to explore the accuracy and safety of the 3D-printed non-coplanar template (3D-PNCT)-assisted 192 Ir interstitial brachytherapy (ISBT) in the treatment of NRCC. Material and methods: A total of 36 patients with NRCC who received 3D-PNCT-guided 192 Ir ISBT in the First Affiliated Hospital of Zhengzhou University from January 2021 to July 2022 were included in this study. There were 36 3D-PNCTs that were designed and printed. The prescribed dose was 30–36 Gy, divided into five to six times, once a week. To evaluate whether the actual parameters were consistent with the preoperative design, the dosimetric parameters of pre- and postoperative treatment plans were compared, including dose of 90% high-risk clinical target volume (HR-CTV D90), volume percentage of 100% and 150% prescribed dose V 100% and V 150 %, homogeneity index (HI), conformal index (CI), external index (EI), and dose received by 2 cm 3 (D2cm 3 ) of the rectum, colon, bladder, and ileum. The safety parameters including occurrence of bleeding, infection, pain, radiation enteritis, and radiation cystitis within 3 months after operation were recorded. Results: All patients successfully completed the treatment and achieved the goals of the preoperative plan. There was no significant difference in the accuracy (HRCTVD90, V 100% , EI, CI, and HI) and safety (D2cm 3 of rectum, colon, bladder, and ileum) parameters of the postoperative plan compared with the preoperative plan (all p >0.05). Major side effects included bleeding at the puncture site (13.9%), postoperative pain (8.3%), acute radiation cystitis (13.9%), and radiation enteritis (19.4%). There were no serious perioperative complications and no grade 3–4 acute radiotherapy side effects. Conclusion: 3D-PNCT-assisted 192 Ir ISBT can be accurately and safely applied in the treatment of patients with NRCC.

oncology
3D-printed individual template brachytherapy for the treatment of intractable central pelvic recurrent cervical cancer: A single institution experience

Xiaolu Zhu,Manting Zeng,Youyi Dai,Weilu Kuang,Zijian Zhang,Shan Li,Hong Zhu

DOI: https://doi.org/10.1016/j.brachy.2024.05.004

IF: 2.441

2024-09-06

Brachytherapy

Abstract:Objective: The prognosis of recurrent cervical cancer tends to be poor and there are limited effective treatments currently available for these patients. This study was developed to find a safe and effective treatment for patients with central pelvic recurrent cervical cancer. Materials and methods: This retrospective study analyzed patients with central pelvic recurrent cervical cancer who received 3D-printed individual template (3D-PIT) brachytherapy between February 2019 and June 2023. Analyses of dosimetric parameters, toxicity-related complications, and survival were conducted based on the data of these patients. Results: Twenty-one patients with central pelvic recurrent cervical cancer patients were enrolled. All of them received 3D-printed individual template (3D-PIT) brachytherapy. The mean respective adjusted cumulative HRCTV-D90 and HRCTV-D98 values for these patients were 86.9 Gy and 75.4 Gy. And the local control (LC) rate of these patients was 57.1%. In these 21 patients, only 2 (9.5%) of them experienced grade 3-4 rectal adverse reactions, while 7 (33.3%) patients experienced grade 3-4 bladder adverse reactions. 5(23.8%) patients had fistula, while 3 of these 5 patients had undergone prior anti-VEGF targeted drug treatment which is a risk factor of fistula. The respective 2-year rates of overall and progression-free survival (OS and PFS) for these patients were 72.9% and 57.4%, with a 26-month median PFS. Conclusions: These single-institution data highlight the potential viability of 3D-PIT brachytherapy as an approach to managing intractable central pelvic recurrent cervical cancer following first-line treatment.
FMECA Application to Intraoperative Electron Beam Radiotherapy Procedure As a Quality Method to Prevent and Reduce Patient's Risk in Conservative Surgery for Breast Cancer

Cristiana Vidali,Mara Severgnini,Monica Urbani,Licia Toscano,Alfredo Perulli,Marina Bortul

DOI: https://doi.org/10.3389/fmed.2017.00138

2017-08-28

Abstract:Introduction: Failure Mode Effects and Criticalities Analysis (FMECA) represents a prospective method for risk assessment in complex medical practices. Our objective was to describe the application of FMECA approach to intraoperative electron beam radiotherapy (IOERT), delivered using a mobile linear accelerator, for the treatment of early breast cancer as an anticipated boost. Materials and methods: A multidisciplinary Working Group, including several different professional profiles, was created before the beginning of clinical practice in 2012, with the purpose of writing the Flow Chart and applying the FMECA methodology to IOERT procedure. Several criticalities were identified a priori in the different steps of the procedure and a list of all potential failure modes (FMs) was drafted and ranked using the risk priority number (RPN) scoring system, based on the product of three parameters: severity, occurrence, and detectability (score between 1 and 5). The actions aimed at reducing the risk were then defined by the Working Group and the risk analysis was repeated in 2014 and in 2016, in order to assess the improvement achieved. Results: Fifty-one FMs were identified, which represented the issues prospectively investigated according to the FMECA methodology. Considering a set threshold of 30, the evaluated RPNs show that 33 out of 51 FMs are critical; 6 are included in the moderate risk class (RPN: 31-40); 16 in the intermediate risk class (RPN: 41-50), and 11 in the high risk class (RPN: >50). Discussion: The most critical steps concerned the surgical procedure and IOERT set-up. The introduction of the corrective actions into the clinical practice achieved the reduction of the RPNs in the re-analysis of the FMECA worksheet after 2 and 4 years, respectively. Conclusion: FMECA proved to be a useful tool for prospective evaluation of potential failures in IOERT and contributed to optimize patient safety and to improve risk management culture among all the professionals of the Working Group.
Analysis on the Accuracy of CT-guided Radioactive I-125 Seed Implantation with 3D Printing Template Assistance in the Treatment of Thoracic Malignant Tumors.

Zhe Ji,Haitao Sun,Yuliang Jiang,Yi Chen,Fuxin Guo,Jinghong Fan,Junjie Wang

DOI: https://doi.org/10.1093/jrr/rrab068

2021-01-01

Journal of Radiation Research

Abstract:This article analyzes the accuracy of needle track and dose of a 3-dimensional printing template (3DPT) in the treatment of thoracic tumor with radioactive I-125 seed implantation (RISI). A total of 28 patients were included. The technical process included: (i) preoperative CT positioning, (ii) preoperative planning design, (iii) 3DPT design and printing, (iv) 3DPT alignment, (v) puncture and seed implantation. The errors of needle position and dosimetric parameters were analyzed. A total of 318 needles were used. The mean errors in needle depth, needle insertion point, needle tip and needle angle were 0.52 ± 0.48 cm, 3.4 ± 1.7 mm, 4.4 ± 2.9 mm and 2.8 ± 1.7°, respectively. The differences between actual needle insertion angle and needle depth and those designed in the preoperative were statistically significant (p < 0.05). The mean values of all the errors of the chest wall cases were smaller than those of the lungs, and the differences were statistically significant (p < 0.05). There was no significant difference between the D90 calculated in the postoperative plan and those designed in the preoperative and intraoperative plans (p > 0.05). Some dosimetric parameters of preoperative plans such as V100, V200, CI and HI were not consistent with that of preoperative plans, and the difference was statistically significant (p < 0.05). However, there were no statistical difference in the dosimetric parameters between the postoperative plans and intraoperative plans (p > 0.05). We conclude that for thoracic tumors, even under the guidance of 3DPT, there will be errors. The plan should be optimized in real time during the operation.
Comparison of 3D-printed multichannel non-co-planar vaginal applicators and single-channel vaginal applicators for brachytherapy with positive or close surgical margins in cervical cancer

Chengjun Feng,Xiaomin Wen,Shiting Li,Li Hua,Shaojun Chen

DOI: https://doi.org/10.1016/j.brachy.2024.06.004

IF: 2.441

2024-08-24

Brachytherapy

Abstract:Objective: This study was conducted to compare the differences between 3D-printed multichannel non-co-planar vaginal applicators and single-channel vaginal applicators in cervical cancer patients with positive or close surgical margins. Methods: Between January 2015 and June 2023, 104 cervical cancer patients who underwent radical surgery with positive or close surgical margins were enrolled to receive concurrent intensity-modulated chemoradiotherapy combined with 3D-printed multichannel non-co-planar vaginal applicators (3D-printed group, 41 patients) or single-channel vaginal applicators (single-channel group, 63 patients) guided brachytherapy. The dosimetric parameters, 5-year local control (LC), progression-free survival (PFS), overall survival (OS) of two groups were retrospectively analyzed. Results: The high-risk clinical target volume (D90, D100) and high-dose volume fraction (V150) in 3D-printed group were significantly higher than those in single-channel group (p < 0.05), and the homogeneity index (HI) and conformal index (COIN) were equally better in 3D-printed group. In 3D-printed group, the D2cc, D1cc, and D0.1cc of the bladder and rectum were significantly lower than those of the single-channel group (p < 0.05). The 3D-printed group had significantly superior 5-year LC (70.0% vs. 51.3%, p = 0.041) and PFS (63.0% vs. 44.2%, p = 0.045), but OS were not significantly different between treatment groups (75.4% vs. 59.7%, p = 0.112). The incidence of radiation enteritis and cystitis was lower in the 3D-printed group than in the single-channel group, but no statistical difference was noted. Conclusions: The 3D-printed multichannel non-co-planar vaginal insertion applicators show the advantage of target dose, improve the LC and PFS in patients with positive or close surgical margins after cervical cancer surgery. Thus, the popularization of this method and its application may be of value.
The Clinical Results and Physical Dosimetry Study of 3D-Printing Template Assisted with CT-Guidance for 125I Seed Brachytherapy in Recurrent or Metastatic Gynecologic Carcinoma

Y. Liu,P. Jiang,Y. Jiang,H. Zhang,A. Qu,Z. Ji,F. Guo,H. Sun,X. Li,S. Tian,W. Li,J. Fan,L. Wang,L. Zou,J. Wang

DOI: https://doi.org/10.1016/j.ijrobp.2019.06.1759

2019-01-01

Abstract:To report the physical dosimetry study and preliminary results of a prospective study evaluating 3D-printing template assisted with CT-guidance for 125I seed brachytherapy to treat recurrent or metastatic gynecological carcinoma. In this retrospective study, with median follow-up of 10 months for all patients, 95 patients were enrolled and analyzed; inclusion criteria were Karnofsky performance status 60 to 100, expected overall survival >3 months, patients were pathologically or radiologically confirmed to be recurrent or metastatic gynecological carcinoma and the tumors were unresectable due to individual rejection or surgeon consultation. All patients have accepted 3D-printing template assisted with CT-guidance for 125I seed brachytherapy. Kaplan-Meier survival analysis was used to estimate local control (LC), overall survival (OS), and progression-free survival (PFS). We analyzed the confounding factors that affected LC, PFS, and OS by using Cox proportional hazards regression model. Acute and late toxic effects were prospectively assigned by using the Radiation Therapy Oncology Group (RTOG) and European Organization for Research and Treatment of Cancer (EORTC) criteria. Of 87 patients (median [range] age, 53 [29-92] years; vulvar cancer, 2 [2%]; endometrial cancer, 10 [11%]; cervical cancer, 72 [83%]; ovarian cancer, 3 [3%]), 32 (37%) were alive at last follow-up. 9 (10%) patients adopted secondary RIS implantation on different sites. 75% quantile LC was 16 months (1-year LC, 85%; 95%CI, 77%-93%). Median PFS was 12 months (1-year PFS, 48%; 95%CI, 36%-59%). Median OS was 15 months (1-year OS, 65%; 95%CI, 54%-76%). On multivariate analysis, GTV D100 >60Gy independently correlative for good LC (hazard ratio [HR], 0.139; 95% CI, 0.037-0.527; P=.004), PFS (HR, 0.346; 95% CI, 0.180-0.666; P=.001) and OS (HR, 0.185; 95% CI, 0. 083-0.416; P<.001). Rates of grade 2 acute radiothermitis, vomiting, proctitis and hematuresis were 2 (2%), 1 (1%), 3 (3%) and 2 (2%). Acute grade 3 proctitis occurred in 1 (1%) patient. Late toxic effects were uncommon: 1 (1%) patient developed an hematuresis (grade 2) and 1 (1%) patient developed an rectovaginal fistula. There were no acute or late grade 5 toxic effects. 125I seed brachytherapy to treat recurrent or metastatic gynecologic carcinoma showed promising clinical outcomes and rates of toxic effects. Further optimization of 125I seed brachytherapy is needed in order to improve the accuracy of treatment.
Automated planning of curved needle channels in 3D printed patient-tailored applicators for cervical cancer brachytherapy

Robin Straathof,Sharline M van Vliet-Pérez,Inger-Karine K Kolkman-Deurloo,Linda S G L Wauben,Remi A Nout,Ben J M Heijmen,Linda Rossi,Jenny Dankelman,Nick J van de Berg

DOI: https://doi.org/10.1088/1361-6560/ad8b08

IF: 3.5

2024-10-26

Physics in Medicine and Biology

Abstract:Purpose Patient-tailored intracavitary/interstitial (IC/IS) brachytherapy (BT) applicators may increase dose conformity in cervical cancer patients. Current configuration planning methods in these custom applicators rely on manual specification or a small set of (straight) needles. This work introduces and validates a two-stage approach for establishing channel configurations in the 3D printed patient-tailored ARCHITECT applicator. Methods For each patient, the patient-tailored applicator shape was based on the first BT application with a commercial applicator and integrated connectors to a commercial (Geneva) intrauterine tube and two lunar ring channels. First, a large candidate set was generated of channels that steer the needle to desired poses in the target region and are contained in the applicator. The channels' centrelines were represented by Bézier curves. Channels running between straight target segments and entry points were optimised and refined to ensure (dynamic) feasibility. Second, channel configurations were selected using geometric coverage optimisation. This workflow was applied to establish patient-tailored geometries for twenty-two patients previously treated using the Venezia applicator. Treatment plans were automatically generated using the in-house developed algorithm BiCycle. Plans for the clinically used configuration, TP clin , and patient-tailored configuration, TP arch , were compared. Results Channel configurations could be generated in clinically feasible time (median: 2651s, range 1826-3812s). All TP arch and TP clin plans were acceptable, but planning aims were more frequently attained with patient-tailored configurations (115/132 versus 100/132 instances). Median CTV IR D 98 and bladder D 2cm 3 doses significantly improved (p < 0.001 and p < 0.01 respectively) in TP arch plans in comparison with TP clin plans, and in approximately half of the patients dosimetric indices improved. Conclusion Automated patient-tailored BT channel configuration planning for 3D printed applicators is clinically feasible. A treatment planning study showed that all plans met planning limits for the patient-tailored configurations, and in selected cases improved the plan quality in comparison with commercial applicator configurations.

engineering, biomedical,radiology, nuclear medicine & medical imaging
Accuracy and Dosimetric Parameters Comparison of 3D-Printed Non-Coplanar Template-Assisted Computed Tomography-Guided Iodine-125 Seed Ablative Brachytherapy in Pelvic Lateral Recurrence of Gynecological Carcinomas

Ang Qu,Ping Jiang,Shuhua Wei,Yuliang Jiang,Zhe Ji,Haitao Sun,Weiyan Li,Yuxia Shao,Jinghong Fan,Junjie Wang

DOI: https://doi.org/10.5114/jcb.2021.103585

2021-01-01

Journal of Contemporary Brachytherapy

Abstract:Purpose: To investigate the accuracy of needle distribution and dosimetric parameter differences of 3D-printing non-coplanar template (3D-PNCT)-assisted computed tomography (CT)-guided iodine-125 seed ablative brachytherapy (I-125-SAB) in gynecological cancer patients with non-central pelvic recurrence between pre-operative plan and post-operative plan. Material and methods: Thirty-eight patients with forty-one non-central pelvic recurrent gynecological carcinomas after radiotherapy were enrolled in this study. All patients received 3D-PNCT-assisted CT-guided I-125-SAB from January 2016 to January 2019. The position, angle, and depth of seed needles were measured in both pre-operative plan and intra-operative real-time plan in brachytherapy treatment planning system (B-TPS). Dosimetric parameters of D-90, D-100, V-100, V-150, and V-200 as well as quality parameters of conformal index (CI), external index (EI), and homogeneity index (HI) were compared between pre-operative plan and post-operative plan. Peri-operation complications and radiation-related toxicity were assessed. Results: Median follow-up time was 12 months (range, 5-34 months). Prescribed dose was 100-170 Gy (median, 120 Gy). Radioactivity of I-125 seed was 0.4-0.7 mCi (median, 0.55 mCi). Mean depth deviation for 499 needles was 0.8 +/- 1.0 cm. Mean angular deviation was 2.2 +/- 2.1 degrees. Mean tip distance deviation of needles was 0.4 +/- 0.3 cm. There were significant differences between pre-operative and post-operative plans in CI (p = 0.001) and EI (p = 0.005). No significant differences were shown in D-90, DD90, D-100, V-100, V-150, V-200, and HI between pre-operative and post-operative plans. Only few patients suffered from <= grade 2 toxicities. Conclusions: 3D-PNCT-assisted CT-guided I-125-SAB is safe and feasible for non-central pelvic recurrence of gynecological cancer. All complications are tolerable and mild.
Dosimetry Verification of Radioactive Seed Implantation with 3D Printing Template and CT Guidance for Paravertebral/retroperitoneal Malignant Tumor

Z Ji,Y L Jiang,F X Guo,R Peng,H T Sun,J H Fan,J

DOI: https://doi.org/10.3760/cma.j.issn.0376-2491.2017.13.007

2017-01-01

Abstract:Objective: To compare the dose distributions of postoperative plans with preoperative plans for seeds implantations of paravertebral/retroperitoneal tumors assisted by 3D printing guide template and CT guidance, explore the effects of the technology for seeds implantations in dosimetry level and provide data support for the optimization and standardization in seeds implantation. Methods: Between December 2015 and July 2016, a total of 10 patients with paravertebral/retroperitoneal tumors (12 lesions) received 3D printing template assist radioactive seeds implantations in department of radiation oncology of Peking University Third Hospital, and included in the study. The diseases included cervical cancer, kidney cancer, abdominal stromal tumor, leiomyosarcoma of kidney, esophageal cancer and carcinoma of ureter. The prescribed doses was 110-150 Gy. All patients received preoperative planning design, individual template design and production, and the dose distribution of postoperative plan was compared with preoperative plan. Dose parameters including D(90), MPD, V(100), V(150,)conformal index(CI), EI of target volume and D(2cc) of organs at risk (spinal cord, aorta, kidney). Statistical software was SPSS 19.0 and statistical method was non-parameters Wilcoxon symbols test. Results: A total of 10 3D printing templates were designed and produced which were including 12 treatment areas.The mean D(90) of postoperative target area (GTV) was 131.1 (97.8-167.4 Gy) Gy. The actual seeds number of post operation increased by 3 to 12 in 5 cases (42.0%). The needle was well distributed. For postoperative plans, the mean D(90,)MPD, V(100,)V(150) was 131.1 Gy, 69.3 Gy, 90.2% and 65.2%, respectively, and which was 140.2 Gy, 65.6 Gy, 91.7% and 26.8%, respectively, in preoperative plans. This meant that the actual dose of target volume was slightly lower than preplanned dose, and the high dose area of target volume was larger than preplanned range, but there was no statistical difference in P value between the two groups except V(150)(P=0.004). The actual dose conformity of target volume was worse than preplanned (CI was 0.58 and 0.62, respectively) and the difference was statistically significant(P=0.019). The actual dose of external target volume was higher than preplanned (EI was 55% and 45.9%, respectively) and the difference had no significance. For organs at risk, the actual mean D(2cc) of spinal cord, aorta and kidney was 24.7, 54.4 and 29.7 Gy, respectively, which was higher than preplanned(20.6, 51.6 and 28.6 Gy, respectively), and there was no significant difference in two groups. Conclusions: Most parameters of postoperative validations for 3D printing template assisted seeds implantation in paravertebral/retroperitoneal are closed to the expectations of preoperative plans which means the improvement of accuracy in treatment.
Implementing failure mode and effect analysis to improve the safety of volumetric modulated arc therapy for total body irradiation.

Tara Gray,Alexander Antolak,Saeed Ahmed,Anthony Magnelli,Lan Lu,Young-Bin Cho,Peng Qi,Ping Xia,Sheen Cherian,Erin Murphy,Sarah Kilic,Kim Zura,Emily Rankin,Jenna Schulte,Tiffany Kovacs,Bingqi Guo

DOI: https://doi.org/10.1002/mp.16466

IF: 4.506

2023-01-01

Medical Physics

Abstract:FM and effect analysis was performed to identify high-risk FMs of our VMAT-TBI program. FMEA and FTA were effective in identifying potential FMs and determining the best quality management (QM) measures to implement in the VMAT-TBI program.
The Dosimetry Evaluation of 3D Printing Non-Coplanar Template-Assisted CT-guided 125I Seed Stereotactic Ablation Brachytherapy for Pelvic Recurrent Rectal Cancer after External Beam Radiotherapy.

Hao Wang,Ran Peng,Xuemin Li,Yuxia Wang,Yuliang Jiang,Zhe Ji,Fuxin Guo,Suqing Tian,Haitao Sun,Jinghong Fan,Junjie Wang

DOI: https://doi.org/10.1093/jrr/rraa144

2021-01-01

Journal of Radiation Research

Abstract:ABSTRACT The aim of this study was to investigate the safety and accuracy of computed tomography (CT)-guided 125I seed implantation assisted by a three-dimensional printing non-coplanar template (3D-PNCT) for treating pelvic locally recurrent rectal cancer (LRRC) patients. A total of 13 patients with 18 masses received 125I seed implantation. The dosimetric parameters of pre-implantation and post-implantation were calculated to evaluate the quality of 125I seed implantation. Doses delivered to the organs at risk (OAR) were also calculated. Differences between pre-implantation and post-implantation were compared by the paired t-test. The mean number of 125I seeds pre-implantation and post-implantation was 67.1 and 68.8, respectively. The mean values of D90 (dose that was delivered to 90% of the target volume), D100 (dose that was delivered to 100% of the target volume), V100 (the target volume receiving 100% of the prescription dose) and V150 (the target volume receiving 150% of the prescription dose) pre-implantation and post-implantation were 136.6 and 135.2 Gy, 63.5 and 71.0 Gy, 90.3% and 90.3% and 62.1% and 62.2%, respectively. Dosimetric outcomes were evaluated quantitatively using the dose volume indices, i.e. coverage index (CI), external volume index (EI) and relative dose homogeneity index (HI). The mean values of those indices pre-implantation and post-implantation were 0.62 and 0.61, 0.31 and 0.33, and 0.31 and 0.31, respectively. The mean doses delivered to OAR pre-implantation and post-implantation for the bladder (D2cc) and bowel (D2cc) were 33.4 and 34.4 Gy, and 58.6 and 61.8 Gy, respectively. The parameters mentioned above fitted well, and no significant difference was found among them. It is concluded that CT-guided 125I seed implantation assisted by 3D-PNCT could be a safe and accurate salvage modality for treating LRRC patients; the ideal pre-prescription dose could be achieved. Also, addition of 3D-PNCT could minimize radiation damage to the surrounding normal tissues.
3D-printing non-coplanar template assisted 125I seed implantation for pelvic tumor: individual template design method

Haitao Sun,Lihong Yao,Junjie Wang,Fugen Zhou,Yuliang Jiang,Zhe Ji,Bo Liu,Fuxin Guo,Ran Peng,Jinghong Fan

DOI: https://doi.org/10.3760/cma.j.issn.0254-5098.2017.07.002

2017-01-01

Abstract:Objective To compare the dosimetric data between preoperative plans and postoperative verification in computed tomography (CT)-guided and 3D-printing non-coplanar templateassisted 125I seed implantation for pelvic tumor,and to explore the feasibility and accuracy of the personalized template designmethod.Methods A total of 51 patients registered from Dec 2015 to Dec 2016 who were applied with 3D-printing guided template assisted radioactive seed implantations in the hospital were included in this study.A prescribed dose of 110-160 Gy was adopted.3D-printing templates were designed and produced for 51 cases.The dosimetric parameters:Dg0,minimum peripheral dose (mPD),V100,V150,V200,conformal index (CI),external index (EI),and homogeneity index (HI) were compared between pre-and post-plans.Results 51 cases' templates were in place well during the operations.Compared with the preoperative planning,the postoperative D90,V100,V150,V200,CI,EI and HI differences had no statistical difference (P ＞ 0.05);mPD is larger than before (t =-2.96,P ＜ 0.05).Conclusions The main dosimetric parameters of postoperative verification were consistent well with the preoperative planning and have good accuracy,which could meet the clinical requirements.
Individual curved‐needle interstitial template created using three‐dimensional printing for brachytherapy for distal parauterine tumor recurrence

Jie Zhang,Chunli Luo,Wenjun Zhang,Junfang Yan,Lang Yu,Jie Qiu

DOI: https://doi.org/10.1002/mp.17424

IF: 4.506

2024-09-19

Medical Physics

Abstract:Background Achieving a clinically acceptable dose distribution with commercial vaginal applicators for brachytherapy of recurrent parauterine tumors is challenging. However, the application of three‐dimensional (3D) printing technology in brachytherapy has been widely acknowledged and can improve clinical treatment outcomes. Purpose This study aimed to introduce an individual curved‐needle interstitial template (ICIT) created using 3D printing technology for high‐dose‐rate (HDR) brachytherapy with interstitial treatment to provide a clinically feasible approach to distal parauterine and vaginal cuff tumors. The entire workflow, including the design, optimization, and application, is presented. Methods Ten patients with pelvic cancer recurrence were examined at our center. The vaginal topography was filled with gauze strips soaked in developer solution, and images were obtained using computed tomography (CT) and magnetic resonance imaging (MRI). Curved needle paths were designed, and ICITs were 3D‐printed according to the high‐risk clinical target volume (HRCTV) and vaginal filling model. The dose and volume histogram parameters of the HRCTV (V100, V200, D90, and D98) and organs at risk (OARs) (D2cc) were recorded. Results All patients completed interstitial brachytherapy treatment with the 3D‐printed ICIT. One patient experienced vaginal cuff tumor recurrence, and nine patients experienced parametrial tumor recurrence (four on the left and five on the right). We used two to five interstitial needles, and the maximum angle of the curved needle was 40°. No source obstruction events occurred during treatment of these 10 patients. The doses delivered to the targets and OARs of all patients were within the dose limits and based on clinical experience at our center. Conclusion The ICIT is a treatment option for patients with distal parauterine tumor recurrence. This method addresses the limitations of vaginal intracavitary and standard interstitial applicators. The ICIT has the advantages of biocompatibility, personalization, and magnetic resonance imaging compatibility.

radiology, nuclear medicine & medical imaging
Shaping success: clinical implementation of a 3D-printed electron cutout program in external beam radiation therapy

Joseph B Schulz,Clinton Gibson,Piotr Dubrowski,Caroline M Marquez,Lynn Million,Yushen Qian,Lawrie Skinner,Amy S Yu,Joseph B. Schulz,Caroline M. Marquez,Amy S. Yu

DOI: https://doi.org/10.3389/fonc.2023.1237037

IF: 4.7

2023-08-10

Frontiers in Oncology

Abstract:Purpose: The integration of 3D-printing technology into radiation therapy (RT) has allowed for a novel method to develop personalized electron field-shaping blocks with improved accuracy. By obviating the need for handling highly toxic Cerrobend molds, the clinical workflow is significantly streamlined. This study aims to expound upon the clinical workflow of 3D-printed electron cutouts in RT and furnish one year of in-vivo dosimetry data. Methods and materials: 3D-printed electron cutouts for 6x6 cm, 10x10 cm, and 15x15 cm electron applicators were designed and implemented into the clinical workflow after dosimetric commissioning to ensure congruence with the Cerrobend cutouts. The clinical workflow consisted of four parts: i) the cutout aperture was extracted from the treatment planning system (TPS). A 3D printable cutout was then generated automatically through custom scripts; ii) the cutout was 3D-printed with PLA filament, filled with tungsten ball bearings, and underwent quality assurance (QA) to verify density and dosimetry; iii) in-vivo dosimetry was performed with optically stimulated luminescence dosimeters (OSLDs) for a patient's first treatment and compared to the calculated dose in the TPS; iv) after treatment completion, the 3D-printed cutout was recycled. Results: QA and in-vivo OSLD measurements were conducted (n=40). The electron cutouts produced were 6x6 cm (n=3), 10x10 cm (n=30), and 15x15 cm (n=7). The expected weight of the cutouts differed from the measured weight by 0.4 + 1.1%. The skin dose measured with the OSLDs was compared to the skin dose in the TPS on the central axis. The difference between the measured and TPS doses was 4.0 + 5.2%. Conclusion: The successful clinical implementation of 3D-printed cutouts reduced labor, costs, and removed the use of toxic materials in the workplace while meeting clinical dosimetric standards.

oncology

[Effect of preoperative irradiation on histological tumor propagation and on the frequency of vaginal recurrence of uterine cancer].

Clinical implementation of failure modes and effects analysis for gynecological high-dose-rate brachytherapy

Practical implementation of failure mode and effects analysis for safety and efficiency in stereotactic radiosurgery

Evaluation and improvement the safety of total marrow irradiation with helical tomotherapy using repeat failure mode and effects analysis

Comparison of failure modes and effects analyses and time for brachytherapy ring and tandem applicator digitization between manual and solid applicator source placement methods

3D-printed brachytherapy in patients with cervical cancer: improving efficacy and safety outcomes

Accuracy Evaluation of a 3D-Printed Individual Template for Needle Guidance in Head and Neck Brachytherapy

Dosimetric parameters and safety analysis of 3D-printing non-coplanar template-assisted interstitial brachytherapy for non-centrally recurrent cervical cancer

3D-printed individual template brachytherapy for the treatment of intractable central pelvic recurrent cervical cancer: A single institution experience

FMECA Application to Intraoperative Electron Beam Radiotherapy Procedure As a Quality Method to Prevent and Reduce Patient's Risk in Conservative Surgery for Breast Cancer

Analysis on the Accuracy of CT-guided Radioactive I-125 Seed Implantation with 3D Printing Template Assistance in the Treatment of Thoracic Malignant Tumors.

Comparison of 3D-printed multichannel non-co-planar vaginal applicators and single-channel vaginal applicators for brachytherapy with positive or close surgical margins in cervical cancer

The Clinical Results and Physical Dosimetry Study of 3D-Printing Template Assisted with CT-Guidance for 125I Seed Brachytherapy in Recurrent or Metastatic Gynecologic Carcinoma

Automated planning of curved needle channels in 3D printed patient-tailored applicators for cervical cancer brachytherapy

Accuracy and Dosimetric Parameters Comparison of 3D-Printed Non-Coplanar Template-Assisted Computed Tomography-Guided Iodine-125 Seed Ablative Brachytherapy in Pelvic Lateral Recurrence of Gynecological Carcinomas

Dosimetry Verification of Radioactive Seed Implantation with 3D Printing Template and CT Guidance for Paravertebral/retroperitoneal Malignant Tumor

Implementing failure mode and effect analysis to improve the safety of volumetric modulated arc therapy for total body irradiation.

The Dosimetry Evaluation of 3D Printing Non-Coplanar Template-Assisted CT-guided 125I Seed Stereotactic Ablation Brachytherapy for Pelvic Recurrent Rectal Cancer after External Beam Radiotherapy.

3D-printing non-coplanar template assisted 125I seed implantation for pelvic tumor: individual template design method

Individual curved‐needle interstitial template created using three‐dimensional printing for brachytherapy for distal parauterine tumor recurrence

Shaping success: clinical implementation of a 3D-printed electron cutout program in external beam radiation therapy